Dishman Carbogen Amcis Limited (NSE:DCAL)
India · Delayed Price · Currency is INR 283.90
-1.50 (-0.53%)
Oct 24, 2025, 3:29 PM IST
Dishman Carbogen Amcis Market Cap
Dishman Carbogen Amcis has a market cap or net worth of 44.51 billion as of October 24, 2025. Its market cap has increased by 73.03% in one year.
Market Cap
44.51B
Enterprise Value
63.08B
Revenue
28.96B
Ranking
n/a
PE Ratio
42.06
Stock Price
283.90
Market Cap Chart
Since September 21, 2017, Dishman Carbogen Amcis's market cap has decreased from 56.82B to 44.51B, a decrease of -21.66%. That is a compound annual growth rate of -2.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 44.51B | 4.96% |
| Dec 31, 2024 | 42.41B | 58.22% |
| Dec 29, 2023 | 26.80B | 80.14% |
| Dec 30, 2022 | 14.88B | -52.91% |
| Dec 31, 2021 | 31.60B | 45.21% |
| Dec 31, 2020 | 21.76B | 59.76% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 21, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.08T |
| Divi's Laboratories | 1.75T |
| Cipla | 1.28T |
| Apollo Hospitals Enterprise | 1.13T |
| Zydus Lifesciences | 1.01T |
| Mankind Pharma | 1.00T |
| Fortis Healthcare | 783.12B |
| Alkem Laboratories | 662.99B |